Fulgent Genetics officer to sell 1,673 shares

FLGT officer Hanlin Gao filed a Rule 144 notice for small tax-related stock sales classified as sell-to-cover transactions.

Rhea-AI Filing Summary

Fulgent Genetics, Inc. (FLGT) has a notice under Rule 144 for sales of common stock by officer Hanlin Gao. The notice covers a planned sale through Morgan Stanley Smith Barney LLC of 1,673 shares of common stock on September 2, 2026, when 27,515,293 shares were outstanding.

The shares relate to 37,790 restricted shares that vested on February 25, 2025 as equity compensation for services. Gao also reported sales of 1,688 shares on June 2, 2026 and 939 shares on August 27, 2026. All transactions are stated to be “sell to cover” for tax withholding, not discretionary trading.

Key Figures

Shares covered by current notice: 1,673 shares Aggregate market value of shares in notice: $32,885.20 Shares outstanding: 27,515,293 shares +3 more

6 metrics

Shares covered by current notice 1,673 shares Common stock to be sold through broker as of September 2, 2026

Aggregate market value of shares in notice $32,885.20 Value of 1,673 shares of common stock in current Form 144

Shares outstanding 27,515,293 shares Fulgent Genetics common stock outstanding as of September 2, 2026

Restricted shares vested 37,790 shares Restricted stock vesting on February 25, 2025 as equity compensation

Shares sold June 2, 2026 1,688 shares Past 3 months sales reported, proceeds $30,190.71

Shares sold August 27, 2026 939 shares Past 3 months sales reported, proceeds $18,691.05

Key Terms

Rule 144, Restricted Stock Units, Restricted stock vest, Equity compensation for services rendered, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Restricted stock vest financial

"Common Stock | 02/25/2025 | Restricted stock vest | Fulgent Genetics, Inc."

A restricted stock vest is the moment when shares granted to an employee or executive under conditions (like staying at the company or hitting targets) officially become theirs to keep or sell. Think of it as a timed gift that unlocks only after certain rules are met. Investors watch vesting because it can change who controls shares, create potential selling pressure when large blocks unlock, and reveal how management’s incentives are aligned with company performance.

Equity compensation for services rendered financial

"37790 | 02/25/2025 | Equity compensation for services rendered"

sell to cover financial

"were made to satisfy tax withholding obligations through "sell to cover" transactions"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

FAQ

What does the Form 144 filing disclose for Fulgent Genetics, Inc. (FLGT)?

The filing reports that officer Hanlin Gao filed a Rule 144 notice covering a planned sale of 1,673 FLGT common shares on September 2, 2026 through Morgan Stanley Smith Barney LLC, related to previously vested restricted stock.

How many Fulgent Genetics (FLGT) shares are covered by the Rule 144 notice?

The notice covers 1,673 shares of Fulgent Genetics common stock, with an aggregate market value of $32,885.20 as reported in the form.

How many Fulgent Genetics (FLGT) shares did Hanlin Gao sell in the past 3 months?

The filing lists sales of 1,688 shares on June 2, 2026 for $30,190.71 and 939 shares on August 27, 2026 for $18,691.05 of Fulgent Genetics common stock.

What is the purpose of the FLGT stock sales reported by Hanlin Gao?

According to the filing, the sales, including those in the past 3 months, were made to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units, using “sell to cover” transactions and not as discretionary trades.

How many FLGT restricted shares are related to this Form 144 filing?

The securities to be sold are tied to 37,790 shares of restricted stock that vested on February 25, 2025, described as equity compensation for services rendered by Fulgent Genetics, Inc.

How many Fulgent Genetics (FLGT) shares were outstanding at the time of the notice?

The Form 144 states that 27,515,293 shares of Fulgent Genetics common stock were outstanding as of September 2, 2026, when the notice for the 1,673-share sale was filed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 08:42 PM Accepted by SEC EDGAR 09/02/2026 - 08:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001684532
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FULGENT GENETICS, INC.
SEC File Number	001-37894
Address of Issuer	4399 Santa Anita Ave El Monte CALIFORNIA 91731
Phone	626-350-0537
Name of Person for Whose Account the Securities are To Be Sold	Gao Hanlin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th FL New York NY 10004	1673	32885.20	27515293	09/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/25/2025	Restricted stock vest	Fulgent Genetics, Inc.			37790	02/25/2025	Equity compensation for services rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Hanlin Gao C/O Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte CA 91731	Common Stock	06/02/2026	1688	30190.71
Hanlin Gao C/O Fulgent Genetics, Inc. 4399 Santa Anita Avenue El Monte CA 91731	Common Stock	08/27/2026	939	18691.05

144: Remarks and Signature

Remarks	Shares sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale, along with sales during the past 3 months, were made to satisfy tax withholding obligations through "sell to cover" transactions and do not represent a discretionary trade by the reporting person.
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Paul Kim as Attorney-In-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)